Prescreening Study to Identify Potential Stargardt Participants for ACDN-01 Clinical Trials (STARPATH)
Start Date
6/20/2024
Completion Date
8/31/2030
Summary
This is an observational prescreening study. Individuals who are eligible for prescreening will undergo testing procedures that may be used to determine eligibility in ACDN-01 clinical trials.
Detailed Description
The prescreening process will be used to help determine the initial eligibility and interest of potential participants in ACDN-01 clinical trials by conducting assessments of key eligibility criteria before the clinical trial screening procedures are performed.
Eligibility Criteria
Age Range: 5 years to No maximum
Interventions
Prescreening Assessments
Conditions
Locations
University of San Francisco
San Francisco, California 94158
United States
Vitreo Retinal Associates
Gainesville, Florida 32607
United States
Wilmer Eye Institute at John Hopkins
Baltimore, Maryland 21218
United States
Massachusetts Eye and Ear
Boston, Massachusetts 02114
United States
University of Michigan Kellogg Eye Center
Ann Arbor, Michigan 48105
United States
Cincinnati Eye Institute
Cincinnati, Ohio 45245
United States
Retina Foundation of Texas
Dallas, Texas 75382
United States
Retina Consultants of Texas
Houston, Texas 77401
United States